Olanzapine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0527-3164 -
Package NDC
0527-3164-32 -
Application number
ANDA208146 -
SPL ID
002da62b-aec3-8e2a-e063-6294a90a5efc -
SPL set ID
002dd00f-7946-ea4f-e063-6294a90a5916 -
UNII
N7U69T4SZR -
RxCUI
312076 -
RxCUI
314155 -
RxCUI
351107 -
RxCUI
351108
What the source publishes
- Labeler
- Lannett Company, Inc.
- Active ingredients
- Olanzapine
- Form
- TABLET, ORALLY DISINTEGRATING
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Olanzapine",
"splId": "002da62b-aec3-8e2a-e063-6294a90a5efc",
"labels": [
{
"setId": "002dd00f-7946-ea4f-e063-6294a90a5916",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=002dd00f-7946-ea4f-e063-6294a90a5916",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=002dd00f-7946-ea4f-e063-6294a90a5916"
}
],
"routes": [
"ORAL"
],
"labeler": "Lannett Company, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0527-3164-32)",
"package_ndc": "0527-3164-32",
"identifierStatus": "well-formed",
"marketing_start_date": "20230701"
}
],
"productId": "0527-3164_002da62b-aec3-8e2a-e063-6294a90a5efc",
"useDomain": "unknown",
"dosageForm": "TABLET, ORALLY DISINTEGRATING",
"productNdc": "0527-3164",
"deaSchedule": null,
"genericName": "Olanzapine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "OLANZAPINE",
"strength": "20 mg/1"
}
],
"applicationNumber": "ANDA208146",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230530",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175430"
],
"upc": [
"0305273163323",
"0305273164320",
"0305273161329",
"0305273162326"
],
"unii": [
"N7U69T4SZR"
],
"rxcui": [
"312076",
"314155",
"351107",
"351108"
],
"spl_set_id": [
"002dd00f-7946-ea4f-e063-6294a90a5916"
],
"pharm_class_epc": [
"Atypical Antipsychotic [EPC]"
],
"manufacturer_name": [
"Lannett Company, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0527-3164_002da62b-aec3-8e2a-e063-6294a90a5efc"